Key facts
| Price (PPV) | 224 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | amlodipinevalsartan |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DB01 |
| Manufacturer | NOVARTIS PHARMA MAROC |
| Presentation | Boîte de 28 |
| Nature | Médicament |
| Hospital price | 140.40 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'hypertension artérielle essentielle. Exforge est indiqué pour les patients dont la tension artérielle est insuffisamment contrôlée par le valsartan seul ou par l'amlodipine seule. Exforge est indiqué pour le traitement initial de l'hypertension artérielle. La décision de prescrire Exforge en traitement initial de l'hypertension artérielle doit reposer sur une évaluation des bénéfices et des risques potentiels. Source : Compendium.ch - Date : 20 octobre 2025
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 5 other products contain the same active substance as Exforge 5 mg / 160 mg (Amlodipine | Valsartan), at the same strength and in the same dosage form. For the same pack size (Boîte de 28), the cheapest is Suliat 5 mg / 160 mg (AFRIC-PHAR) at 185.20 MAD, i.e. 17 % less than Exforge 5 mg / 160 mg (224 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Suliat 5 mg / 160 mg | AFRIC-PHAR | Boite de 28 | 185.20 MAD | 6.61 / unit | −17 % |
| Xilam 5 mg / 160 mg | SOTHEMA | Boite de 28 | 185.20 MAD | 6.61 / unit | −17 % |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Suliat 5 mg / 160 mg | AFRIC-PHAR | Boite de 14 | 105.20 MAD | 7.51 / unit |
| Valmep 5 mg / 160 mg | COOPER PHARMA | Boite de 30 | 164.60 MAD | 5.49 / unit |
| Lotevan 5 mg / 160 mg | ZENITH PHARMA | Boite de 30 | 198.20 MAD | 6.61 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Exforge 5 mg / 160 mg
Exforge 5 mg / 160 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by NOVARTIS PHARMA MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Exforge 5 mg / 160 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Exforge 5 mg / 160 mg
Answers to common questions from Moroccan patients about this drug.